FDA approves CGuard Prime for TCAR, but the supporting trial included just 50 patients and had no comparison group

Regulatory Approvals — FDA approves CGuard Prime for TCAR, but the supporting trial included just 50 patients and had no comparison group  Medical Daily

Read the original at Regulatory Approvals ↗

Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. November 15, 2026.

By